Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Hajime Tanaka

Assistant Professor

Tokyo Medical and Dental University

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Medical Imaging Medical Imaging professors in Japan

About

Hajime Tanaka is an Assistant Professor at Tokyo Medical and Dental University in Japan. His research focuses on the clinical outcomes and treatment strategies for bladder cancer, particularly in relation to therapies such as chemoradiation and nephrectomy. He has contributed to multiple studies assessing prognostic factors in urothelial carcinoma and has published editorial comments on bladder cancer management guidelines.

Articles (12)

Year:

2025

Year:

2025

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Yuma Waseda

Tokyo Institute of Technology

JAPAN

View details

soichiro yoshida

Institute of Science Tokyo

JAPAN

View details

Ithaar Derweesh

Professor and Director of Urologic Oncology

Rush University Medical Center

UNITED STATES

View details

Motohiro Fujiwara

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Giovanni Lughezzani

Full Staff Urologist

Humanitas University

ITALY

View details

Kazutaka Saito

Professor and Chair

Jichi Medical University Saitama Medical Center

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hajime Tanaka

Research Interests

Make your next move.

Explore related searches

About

Articles (12)

Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer

Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma

Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study

Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review

Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy

Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy

Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort

Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision

Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence

Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management

Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer

Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC)

Collaborators (6)

Yuma Waseda

soichiro yoshida

Ithaar Derweesh

Motohiro Fujiwara

Giovanni Lughezzani

Kazutaka Saito

Make your next move.